companyprofile
Actions
Saudi Chemical Co.
- Main Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close 9.95
-
Open 9.94
-
High 10.06
-
Low 9.59
-
No. of Trades 3,282
-
Avg. Trade size* 780
-
Volume Traded 2,559,417
-
Value Traded (SAR) 25,196,930.91
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 26/12/2023 | 25/01/2024 | 04/02/2024 | Account Transfer | 0.05 |
| 19/12/2022 | 18/01/2023 | 29/01/2023 | Account Transfer | 0.50 |
| 23/12/2021 | 23/01/2022 | 03/02/2022 | Account Transfer | 0.50 |
| 08/04/2021 | 26/05/2021 | 14/06/2021 | Account Transfer | 0.50 |
| 09/09/2018 | 02/12/2018 | 16/12/2018 | Account Transfer | 1.25 |
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2023-12-31 | |||
|---|---|---|---|---|
| Total Assets |
4,906,730
|
- | - | - |
| Total Liabilities |
3,097,642
|
- | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
1,800,287
|
- | - | - |
| Total Liabilities and Shareholders Equity |
4,897,929
|
- | - | - |
| Statement of Income | 2023-12-31 | |||
| Total Revenue (Sales/Operating) |
4,854,848
|
- | - | - |
| Net Profit (Loss) before Zakat and Tax |
217,800
|
- | - | - |
| Zakat and Income Tax |
-33,668
|
- | - | - |
| Net Profit (Loss) after Zakat and Tax |
182,886
|
- | - | - |
| Total Comprehensive Income |
182,564
|
- | - | - |
| Profit (Loss) per Share |
0.22
|
- | - | - |
| Cash Flows | 2023-12-31 | |||
| Net Cash From Operating Activities |
433,023
|
- | - | - |
| Net Cash From Investing Activities |
-62,690
|
- | - | - |
| Net Cash From Financing Activities |
-327,439
|
- | - | - |
| Cash and Cash Equivalents, Beginning of the Period |
91,215
|
- | - | - |
| Cash and Cash Equivalents, End of the Period |
134,109
|
- | - | - |
| All Figures in | Thousands | |||
| All Currency In | SAR | |||
| Last Update Date | 2024-03-18 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
|---|---|---|---|---|
| Total Assets |
6,470,041
|
5,778,591
|
5,642,924
|
5,281,424
|
| Total Liabilities |
4,421,646
|
3,803,823
|
3,741,575
|
3,519,253
|
| Total Shareholders Equity (After Deducting the Minority Equity) |
2,037,446
|
1,964,452
|
1,891,741
|
1,753,764
|
| Total Liabilities and Shareholders Equity |
6,459,092
|
5,768,275
|
5,633,316
|
5,273,017
|
| Statement of Income | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
| Total Revenue (Sales/Operating) |
1,353,614
|
1,615,025
|
1,644,963
|
1,200,005
|
| Net Profit (Loss) before Zakat and Tax |
85,524
|
87,210
|
101,927
|
43,005
|
| Zakat and Income Tax |
-11,898
|
-13,791
|
-9,666
|
-7,905
|
| Net Profit (Loss) after Zakat and Tax |
72,993
|
73,419
|
91,454
|
35,100
|
| Total Comprehensive Income |
72,993
|
73,419
|
91,454
|
35,362
|
| Profit (Loss) per Share |
0.09
|
0.09
|
0.11
|
0.04
|
| Cash Flows | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
| Net Cash From Operating Activities |
-159,953
|
-18,390
|
-171,699
|
83,692
|
| Net Cash From Investing Activities |
-27,039
|
-12,633
|
-7,747
|
-31,919
|
| Net Cash From Financing Activities |
178,017
|
108,933
|
228,373
|
13,780
|
| Cash and Cash Equivalents, Beginning of the Period |
134,109
|
134,109
|
134,109
|
91,215
|
| Cash and Cash Equivalents, End of the Period |
125,134
|
212,019
|
183,036
|
156,768
|
| All Figures in | Thousands | Thousands | Thousands | Thousands |
| All Currency In | SAR | SAR | SAR | SAR |
| Last Update Date | 2024-11-11 | 2024-08-13 | 2024-05-20 | 2023-11-12 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
1-Explosives for cival use 2-Certain military materials and explosives 3- Trading and manufacturing of certain categories of pharmaceutical products
Company History
Saudi Chemical Company is Leader Company in the industry of civil explosives and for this purpose has three factories in both Riyadh and Jeddah and the Eastern Province and South distribution warehouses in the region of Abha. Supplying the local market and the necessary support materials for all civil explosives operations in addition to the export of all the Gulf Arab states and sister and friendly countries. The Company produces the following materials: 1- Prillex 2- Kemulex 3- Sanel . These products are the large proportion of confidence to access the International Quality Certificate ISO 9000/2000. The company posts effective in most infrastructure projects carried out in the Kingdom such as Roads, Airports, Bridges, Tunnels, mining and quarrying projects, ditches, terracing and the settlement of land and demolition of buildings and water wells. The company has aspirations towards a better future where intend to enter into military areas by placing the first building blocks of the establishment of an industrial base specializes in Military fields. In addition to the company''''s purchase of 99% of the Saudi International Trading Co., Ltd. shares (Sitco), which is one of the major pharmaceutical and medical products and solutions, trading companies. In order to expand its activities and the diversity of its services the national economy and the presence of a giant Company enjoys the confidence of the public and private sectors.
Company Bylaws
Equity Profile
- Authorized Capital (SAR) 843,200,000
- Issued Shares 843,200,000
- Paid Capital (SAR) 843,200,000
- Par Value/Share 1
- Paid Up Value/Share 1
Last Update :2023-06-22
Investment limits
There are no investment limits on the company shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company bylaw and the issued instructions by the related regulators and supervisory authorities
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Khalid Mohammed Albawardi
Company Address:
P.O.BOX 2665 Riyadh 11461 Saudi Arabia
Contact Details:
Telephone:
0114515771
Fax
: 0112066349
Email
: K.Albawardi@saudichemical.com
Company Website:
| Name Of Subsidiary | Percentage Of Property | Main Business | Location Of Operation | Country Of Operation |
|---|---|---|---|---|
| Saudi International Trading Company (SITCO Pharma) | 99.00% | Is agent to highest international pharmaceutical companies in the Kingdom of Saudi Arabia. | ksa | ksa |
| Suez International Nitrates Company(Sinco) | 100.00% | Manufacturing Ammonium Nitrate | ksa | egybt |
| Chemical Company for Commercial Investment Ltd. | 100.00% | Marketing and sales pharmacies and medicines. | ksa | ksa |
| AJA Pharma Company Ltd. | 100.00% | factory for Manufacturing pharmaceuticals and medical products. | ksa | ksa |
| Saudi Chemical Co. Ltd. | 100.00% | Manufacturing Civilian and Military explosives | ksa | ksa |
| Care Supply Chain for Logistic Services Co. Ltd. | 50.00% | Logistics Services - transportation, loading, unloading, warehousing, and distribution services | ksa | ksa |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
- ${title}${badge}